EDGAR Filing Documents for 0001178913-22-002245

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001178913-22-002245

Filing Date

2022-05-31

Accepted

2022-05-31 10:30:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	zk2227937.htm	DEFA14A	17348
2		image0.jpg	GRAPHIC	1147
3		image1.jpg	GRAPHIC	84615
	Complete submission text file	0001178913-22-002245.txt		136747

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002

Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156

Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38807 | Film No.: 22981218
SIC: 2834 Pharmaceutical Preparations